PATENT CLAIM ANALYSIS

Application Number: 16155386
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "077000"]

Abstract:
This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.

Claim (Index 3):
Crystalline psilocybin in the form Polymorph A, according to  claim 1  characterised by one or more of:\n a. peaks in an XRPD diffractogram at 11.5, 12.0,14.5, and 17.5, \u00b02\u03b8\u00b10.1\u00b02\u03b8; \n b. peaks in an XRPD diffractogram at 11.5, 12.0, 14.5 and 17.5, \u00b02\u03b8\u00b10.1\u00b02\u03b8, further characterised by at least one further peak at 19.7, 20.4, 22.2, 24.3 or 25.7\u00b02\u03b8\u00b10.1\u00b02\u03b8; \n c. an XRPD diffractogram as substantially illustrated in  FIG. 7 a ; or \n d. an endothermic event in a DSC thermogram having an onset temperature of between 205 and 220\u00b0 C. substantially as illustrated in  FIG. 8 a.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 97.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13922085', '13347423', '16124281', '14386424', '12665192']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.775170465216756
- 35 USC 102 Novelty (BERT): 0.5201182134828387
- Combined Prediction Score: 0.7496652400433643
- Mean Citation Score: 284.004634
- Max Citation Score: 302.94016
- Similarity Product: 202.857979140625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test